Keros Therapeutics logo

Keros Therapeutics

KROS | NASDAQ
Chart Builder DCF Calculator
$10.03
-$0.27 (-2.62%)
At close: Nov 16, 2026, 4:00 PM ET
$10.18
+$0.15 (+1.50%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.62%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
54
Fundamentals Strong
Market Sentiment Neutral
Moat None
Sector Rank #202/1021 (Top 20%)

Key Statistics

Market Data

Market Cap $373.33M
1D Range
9.91 10.74
52W Range
9.17 21.84

Valuation (TTM)

PE -2.85
PB 1.34
EV/EBITDA -2.04

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $20.00
Loading financial charts...

Profile

Keros Therapeutics, Inc., a biopharmaceutical entity in the clinical development phase, is focused on pioneering and commercializing innovative therapies for individuals afflicted by hematological and...

Sector Healthcare
Industry Biotechnology
Employees 92
IPO Date Apr 8, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
$0.7
Beat +172.92%
REV
$40.01M
Beat +170.98%
Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$20.00
Upside
+99.40%
Buy (2)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.